Chronic Obstructive Pulmonary Disease
A daily dose of atorvastatin could reduce pulmonary artery pressure among patients with COPD.
A novel technique involving NPPV reduced the risks of nosocomial infection, requirement for intubation, and hospital mortality in patients with COPD.
Researchers also observed no difference in 30-day mortality rates between patients in the ICU and those who received regular inpatient care in another hospital unit.
A strong inverse association between total fruit and vegetable consumption and COPD was observed in smokers but not in never-smokers.
Patients receiving vitamin D for deficiency without bolus doses experienced the most benefit.
Polyvalent pneumococcal vaccines offered protection against community-acquired pneumonia in COPD patients.
Budesonide/formoterol treatment decreased exacerbations in COPD after 3 months.
Self-estimated life expectancy rates may differ from clinician-estimated rates of survival.
Many patients with COPD report morning symptoms that are negatively associated with physical activity.
The multidisciplinary care intervention did not reduce COPD readmissions or achieve substantial savings.
The GOLD Report includes a revised definition of COPD and updates guidelines for managing exacerbations.
It is important to use the right terminology when discussing medical terms, specifically ones associated with smoke-related respiratory conditions, according to the researchers.
Researchers conducted a systematic review of the effectiveness of monitoring physiological parameters to predict COPD exacerbations.
The prevalence of COPD globally is increasing more rapidly in women than in men.
Researchers conducted a study to verify the CAT as a predictor of outcome among patients with interstitial lung disease.
The CAPTURE questionnaire with peak flow can identify patients who would benefit from COPD therapy.
Long-term supplemental oxygen has no benefit in patients with stable COPD and resting or exercise-induced moderate desaturation.
Researchers used integrated genomics to identify convergent transcriptomic pathways in emphysema and IPF.
Omalizumab is useful in the management of severe asthma with overlapping COPD.
Researchers predict that the number of COPD cases will increase by more than 150% from 2010 to 2030.
Endoscopic sinus surgery improved asthma quality of life and control in patients with uncontrolled asthma.
Exacerbations were associated with accelerated lung function loss in patients with established COPD.
COPD-related mortality was reduced by 12.3% between 2000 and 2014.
The combination may reduce the rate of moderate or severe exacerbations among COPD patients.
Clinician awareness of COPD treatment guidelines has increased since 2007.
Patients with a blood eosinophil count below 2% had a poor response to treatment with inhaled corticosteroids.
Potential effects of statin use as adjunct therapy in COPD patients is still widely debated.
For patients hospitalized with COPD, mortality and length of stay have decreased while financial burden has increased.
The COPD Assessment Test (CAT) can be used to distinguish between newly diagnosed patients, those with more exacerbations, and by gender.
Patients who are socioeconomically disadvantaged are more likely to continue smoking after a COPD diagnosis.